A (dis)integrated stress response: Genetic diseases of eIF2α regulators
- PMID: 34463036
- DOI: 10.1002/wrna.1689
A (dis)integrated stress response: Genetic diseases of eIF2α regulators
Abstract
The integrated stress response (ISR) is a conserved mechanism by which eukaryotic cells remodel gene expression to adapt to intrinsic and extrinsic stressors rapidly and reversibly. The ISR is initiated when stress-activated protein kinases phosphorylate the major translation initiation factor eukaryotic translation initiation factor 2ɑ (eIF2ɑ), which globally suppresses translation initiation activity and permits the selective translation of stress-induced genes including important transcription factors such as activating transcription factor 4 (ATF4). Translationally repressed messenger RNAs (mRNAs) and noncoding RNAs assemble into cytoplasmic RNA-protein granules and polyadenylated RNAs are concomitantly stabilized. Thus, regulated changes in mRNA translation, stability, and localization to RNA-protein granules contribute to the reprogramming of gene expression that defines the ISR. We discuss fundamental mechanisms of RNA regulation during the ISR and provide an overview of a growing class of genetic disorders associated with mutant alleles of key translation factors in the ISR pathway. This article is categorized under: RNA Interactions with Proteins and Other Molecules > Protein-RNA Interactions: Functional Implications RNA in Disease and Development > RNA in Disease Translation > Translation Regulation RNA in Disease and Development > RNA in Development.
Keywords: RNA-protein granules; eIF2α; genetic diseases; integrated stress response; translation.
© 2021 Wiley Periodicals LLC.
References
FURTHER READING
-
- Muhlrad, D., Decker, C. J., & Parker, R. (1994). Deadenylation of the unstable mRNA encoded by the yeast MFA2 gene leads to decapping followed by 5'-->3' digestion of the transcript. Genes & Development, 8(7), 855-866. https://doi.org/10.1101/gad.8.7.855
REFERENCES
-
- Abali, Z. Y., De Franco, E., Karakilic Ozturan, E., Poyrazoglu, S., Bundak, R., Bas, F., Flanagan, S. E., & Darendeliler, F. (2020). Clinical characteristics, molecular features, and Long-term follow-up of 15 patients with neonatal diabetes: A single-centre experience. Hormone Research in Paediatrics, 93(7-8), 423-432.
-
- Abbasi, F., Habibi, M., Enayati, S., Bitarafan, F., Razzaghy-Azar, M., Sotodeh, A., Omran, S. P., Maroofian, R., & Amoli, M. M. (2018). A genotype-first approach for clinical and genetic evaluation of Wolcott-Rallison syndrome in a large cohort of Iranian children with neonatal diabetes. Canadian Journal of Diabetes, 42(3), 272-275.
-
- Abbink, T. E. M., Wisse, L. E., Jaku, E., Thiecke, M. J., Voltolini-González, D., Fritsen, H., Bobeldijk, S., Ter Braak, T. J., Polder, E., Postma, N. L., Bugiani, M., Struijs, E. A., Verheijen, M., Straat, N., van der Sluis, S., Thomas, A. A. M., Molenaar, D., & van der Knaap, M. S. (2019). Vanishing white matter: Deregulated integrated stress response as therapy target. Annals of Clinical Translational Neurology, 6(8), 1407-1422.
-
- Abdel-Nour, M., Carneiro, L. A. M., Downey, J., Tsalikis, J., Outlioua, A., Prescott, D., da Costa, L. S., Hovingh, E. S., Farahvash, A., Gaudet, R. G., Molinaro, R., van Dalen, R., Lau, C. C. Y., Azimi, F. C., Escalante, N. K., Trotman-Grant, A., Lee, J. E., Gray-Owen, S. D., Divangahi, M., … Girardin, S. E. (2019). The heme-regulated inhibitor is a cytosolic sensor of protein misfolding that controls innate immune signaling. Science, 365(6448), eaaw4144. https://doi.org/10.1126/science.aaw4144
-
- Abdulkarim, B., Nicolino, M., Igoillo-Esteve, M., Daures, M., Romero, S., Philippi, A., Senée, V., Lopes, M., Cunha, D. A., Harding, H. P., Derbois, C., Bendelac, N., Hattersley, A. T., Eizirik, D. L., Ron, D., Cnop, M., & Julier, C. (2015). A missense mutation in PPP1R15B causes a syndrome including diabetes, short stature, and microcephaly. Diabetes, 64(11), 3951-3962.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources